Week of 3 August 2026

This week's themes: a contrarian look at why rare-disease launches win or lose before approval even lands, a practical framework for separating real AI value from pharma-AI hype, a quick myth-bust on hydration advice, and a breakdown of how differently each generation trusts a health claim. Two anchor posts (pharma/regulatory, AI in healthcare), two rotating pillars (water tech, generational marketing) — health & wellness rotates in next week.

Images weren’t auto-generated this run — each post carries a ready-to-paste prompt instead.

• #1Draft
  Pharma & regulatoryContrarian take

  The launch plan nobody puts on the Gantt chart

  Everyone in market access says "get payers involved early." After a dozen GI launches, I think that's only half the advice — and the half nobody checks is the one that sinks products.

  Tue · 07:30-09:00

  2,159 / 3,000 · folds at ~210

  no image
• #2Draft
  AI in healthcareFramework/how-tocarousel

  Where AI actually helps in pharma commercial (and where it's still hype)

  I've sat through more "AI will transform pharma" pitches than I can count. Maybe 20% of them survive contact with a real commercial team. Here's the framework I use to tell which is which.

  Wed · 12:00-13:00

  785 / 3,000 · folds at ~210

  no image
• #3Published
  Water technologyMyth-buster

  The hydration myth we keep repeating

  This weekend I noticed something subtle....

  Thu · 07:30-09:00

  540 / 3,000 · folds at ~210

  
• #4Draft
  Marketing across the generationsTrend breakdown

  Four generations, four different paths to the same health decision

  Boomers Google their symptoms. Gen Z asks TikTok. Same health question, completely different buying journey — and most health brands still market to only one of them.

  Fri · 12:00-13:00

  1,010 / 3,000 · folds at ~210

  no image